IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v19y2022i14p8710-d864924.html
   My bibliography  Save this article

Serum Trimethylamine N-Oxide Levels Correlate with Metabolic Syndrome in Coronary Artery Disease Patients

Author

Listed:
  • Chiu-Huang Kuo

    (Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan
    School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien 97004, Taiwan)

  • Chin-Hung Liu

    (Ph.D. Program in Pharmacology and Toxicology, Department of Medicine, School of Medicine, Tzu Chi University, Hualien 97004, Taiwan
    Department of Pharmacology, Tzu Chi University, Hualien 97004, Taiwan)

  • Ji-Hung Wang

    (Division of Cardiology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan
    School of Medicine, Tzu Chi University, Hualien 97004, Taiwan)

  • Bang-Gee Hsu

    (Division of Nephrology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 97004, Taiwan
    School of Medicine, Tzu Chi University, Hualien 97004, Taiwan)

Abstract

Trimethylamine N-oxide (TMAO) is a gut microbial metabolite that affects atherogenesis and glucose dysregulation. The purpose of this study was to look at the link between blood TMAO levels and metabolic syndrome (MetS) in individuals with coronary artery disease (CAD). Blood samples were obtained in fasting status, and serum TMAO level was quantified by high-performance liquid chromatography–mass spectrometry. MetS and its components were defined according to the International Diabetes Federation diagnostic criteria. Of 92 enrolled patients, 51 (55.4%) had MetS. Patients with MetS had a greater proportion of hypertension and diabetes mellitus, higher body weight, waist circumference, body mass index, systolic blood pressure, fasting glucose, triglycerides, blood urea nitrogen, creatinine, C-reactive protein (CRP), insulin level, homeostasis model assessment of insulin resistance, and TMAO level. Multivariable logistic regression models revealed that TMAO level (odds ratio: 1.036, 95% confidence interval: 1.005–1.067, p = 0.023) could be an effective predictor of MetS among the CAD population. In these patients, the log-TMAO level was positively associated with log-CRP (β = 0.274, p = 0.001) and negatively associated with eGFR (β = −0.235, p = 0.022). In conclusion, our study revealed a positive association between serum TMAO level and MetS among patients with CAD.

Suggested Citation

  • Chiu-Huang Kuo & Chin-Hung Liu & Ji-Hung Wang & Bang-Gee Hsu, 2022. "Serum Trimethylamine N-Oxide Levels Correlate with Metabolic Syndrome in Coronary Artery Disease Patients," IJERPH, MDPI, vol. 19(14), pages 1-9, July.
    • Handle: RePEc:gam:jijerp:v:19:y:2022:i:14:p:8710-:d:864924
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/19/14/8710/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/19/14/8710/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Zeneng Wang & Elizabeth Klipfell & Brian J. Bennett & Robert Koeth & Bruce S. Levison & Brandon DuGar & Ariel E. Feldstein & Earl B. Britt & Xiaoming Fu & Yoon-Mi Chung & Yuping Wu & Phil Schauer & Jo, 2011. "Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease," Nature, Nature, vol. 472(7341), pages 57-63, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Zahraa Al Bander & Marloes Dekker Nitert & Aya Mousa & Negar Naderpoor, 2020. "The Gut Microbiota and Inflammation: An Overview," IJERPH, MDPI, vol. 17(20), pages 1-21, October.
    2. Nicole Farmer & Cristhian A. Gutierrez-Huerta & Briana S. Turner & Valerie M. Mitchell & Billy S. Collins & Yvonne Baumer & Gwenyth R. Wallen & Tiffany M. Powell-Wiley, 2021. "Neighborhood Environment Associates with Trimethylamine-N-Oxide (TMAO) as a Cardiovascular Risk Marker," IJERPH, MDPI, vol. 18(8), pages 1-15, April.
    3. Ruth Nussinov & Jason A Papin, 2017. "How can computation advance microbiome research?," PLOS Computational Biology, Public Library of Science, vol. 13(9), pages 1-3, September.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:19:y:2022:i:14:p:8710-:d:864924. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.